Posted on Leave a comment

Bioinformatics Market : Opportunities and Challenges

Bioinformatics Market : Opportunities and Challenges

Key players that provide bioinformatics products and services are Thermo Fisher Scientific (US), Illumina Inc (US), Agilent Technologies (US), QIAGEN (Netherlands), BGI (China), Wuxi NextCODE (China), Eurofins Scientific (Luxembourg), Waters Corporation (US), Sophia Genetics (Switzerland), Partek (US) and DNASTAR (US).

Machine learning in genomics affects multiple touchpoints, including how genetic research is conducted, how clinicians provide patient care, and the accessibility of genomics to individuals interested in learning more about how their heredity may influence their health.

The global bioinformatics market is projected to reach USD 23.89 billion in 2027 from USD 8.09 billion in 2018, at a CAGR of 14.5% during the forecast period.

Will the integration of machine learning and AI in healthcare create opportunities for players in the bioinformatics market?

Machine learning deals with the development and application of computer algorithms that improve with experience by analyzing and understanding large data sets and drawing conclusions. In genomics, machine learning can be used to learn and understand how to recognize the locations of transcription start sites (TSSs) in a genome sequence, which is expected to help in obtaining faster and automated results. Machine learning in genomics affects multiple touchpoints, including how genetic research is conducted, how clinicians provide patient care, and the accessibility of genomics to individuals interested in learning more about how their heredity may influence their health. Efforts are being made to implement AI to help accelerate the use of technology from bench-to-bedside and make precision medicine a more common practice in smart healthcare. The future of medicine is expected to rely on AI, as AI is likely to evolve in a way that helps doctors instead of replacing them.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39

How do the effective management, processing, and analysis of a large volume of data constitute a major challenge in the bioinformatics market?

Rapid advancements in next-generation sequencing (NGS) technologies have generated large volumes of biological data. Data analysis is necessary, as a lot of information is still unexplored in genome analysis. Hence, data that remains after bioinformatics analysis carries huge importance and can be reused. However, most of the current solutions do not adequately solve the challenges of data management in bioinformatics.

The complexity of data results in a proportionate increase in the demand for physical storage, correct and rigorous analysis, and suitable software for visualization. Although Google has come up with Google cloud solutions to store and manage data, questions on the integration of the entire bioinformatics pipeline with different tools from different companies are unanswered. Considering these factors, the effective management, processing, and analysis of a large volume of data at a lower cost constitute a major challenge in the bioinformatics market.

Request Sample Report Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=39

Browse Related Reports:

eClinical Solutions Market by Clinical Trial Phases, Product (CTMS, eCOA, Analytics, RTMS, eTMF, Safety, CDMS, EDC), Delivery Mode (On-Demand, On-premise, Cloud-based), End User (CROs, Hospitals, Pharma/Biopharma Companies) – Global Forecast to 2022

Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User (Academia) – Global Forecasts to 2024

Bioinformatics Services Market by Type (Microbiome, Transcriptome, Virtual Screening, Database Management), Specialty (Medical, Forensics), Application (Proteomics, Metabolomics), End User (Academia, Pharma) – Global Forecast to 2023

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Shelly Singh
Email: Send Email
Phone: 1-888-600-6441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html